
Oppenheimer analyst Rupesh Parikh raised the firm’s price target on Church & Dwight to $124 from $120 and keeps an Outperform rating on the shares after spending time with management.
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CHD | Church & Dwight | 110.84 | 27.83 | 33.53% |
| Name | Price | % Change | |
|---|---|---|---|
| $110.84 | +33.53% |

Oppenheimer analyst Rupesh Parikh raised the firm’s price target on Church & Dwight to $124 from $120 and keeps an Outperform rating on the shares after spending time with management.

BofA raised the firm’s price target on Church & Dwight to $125 from $115 and keeps a Buy rating on the shares. The firm says the company taking a 45%

Wells Fargo raised the firm’s price target on Church & Dwight to $125 from $115 and keeps an Overweight rating on the shares. The firm says the company taking a

Meeting to be held at company headquarters in Ewing, NJ on November 18 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Church & Dwight has signed a definitive agreement to acquire 45% of the shares of BALI Treatment for approximately $225M. The brands have established market leading positions in Germany and

TD Cowen analyst Robert Moskow raised the firm’s price target on Church & Dwight to $115 from $97 and keeps a Hold rating on the shares. The firm said its

Barclays analyst Lauren Lieberman raised the firm’s price target on Church & Dwight to $89 from $83 and keeps an Underweight rating on the shares. The company’s organic sales trends

UBS raised the firm’s price target on Church & Dwight to $112 from $106 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source

JPMorgan raised the firm’s price target on Church & Dwight to $109 from $105 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source

Citi raised the firm’s price target on Church & Dwight to $110 from $105 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 19, 2026 | ||||
| buy | Assigned | Nov 17, 2026 | ||||
| buy | Reiterated | Nov 17, 2026 | ||||
| sell | Reiterated | Nov 3, 2026 | ||||
| hold | Reiterated | Nov 3, 2026 | ||||
| hold | Assigned | Nov 2, 2026 | ||||
| buy | Reiterated | Nov 2, 2026 | ||||
| hold | Reiterated | Nov 2, 2026 | ||||
| hold | Assigned | Nov 2, 2026 | ||||
| hold | Reiterated | Nov 2, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Jan 29, 2027TBA | $25.89B | $1.02 | $1.64B | 1.01 | 34.00 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.